Note: Ingredients listed on restricted chemical lists
EC/CAS
12767-90-7
Name of the chemical
Hexaboron dizinc undecaoxide
Concentration
N/A
EC/CAS
1897-45-6
Name of the chemical
Chlorthalonil (ISO); Tetrachlorisophthalonitril (790/2009)
Concentration
N/A
General Information
Revision date
2017-03-24
Product name
43ADS1NL
supplier name
1-800-424-9300 (Inside US)
Manufacturer Name
A/D FIRE PROTECTION SYSTEMS
Emergency telephone
+1 703 5273887 (Outside US
Icons in SDS
Company Information
company name
1-800-424-9300 (Inside US)
e-mail address of the competent person responsible for the Safety Data Sheet
ehs@stoncor.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319, H351, H361, H412
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
2.1 Classification of the substance or mixture
Hazardous to the aquatic environment, Chronic, category 3 Carcinogenicity, category 2 Eye Irritation, category 2 Reproductive Toxicity, category 2
2.2 Label elements
Symbol(s) of Product
Signal word
warning Named Chemicals on Label ZINC BORATE, GLASS OXIDE
Hazard statements
Eye Irritation, category 2 H319 Causes serious eye irritation. Carcinogenicity, category 2 H351 Suspected of causing cancer. Reproductive Toxicity, category 2 H361 Suspected of damaging fertility or the unborn child. Hazardous to the aquatic environment, H412 Harmful to aquatic life with long lasting effects. Chronic, category 3
Precautionary statements
P273 Avoid release to the environment. P280 Wear protective gloves/protective clothing/eye protection/ face protection. P284 Wear respiratory protection. P305+351+338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do so. Continue rinsing. P308+313 IF exposed or concerned: Get medical advice/attention P308+P313 IF exposed or concerned: Get medical advice/attention
2.3 Other hazards
No Information
Results of PBT and vPvB assessment
The product does not meet the criteria for PBT/VPvB in accordance with Annex XIII.